For oral or tube feeding use
Chen Y, Zhang J, Tian Y, Xu X, Wang B, Huang Z, et al
Rhythm Pharmaceuticals Setmelanotide Setmelanotide, an Melanocortin-4 Receptor (MC4R) agonists designed to treat hyperphagia and severe obesity , is approved by the US FDA to reduce excess body weight and maintain weight reduction long term in adult and pediatric patients 2 years of age and older with syndromic or monogenic obesity due to Bardet-Biedl syndrome (BBS) or genetically confirmed pro-opiomelanocortin (POMC), including proprotein convertase subtilisin/kexin type 1 (PCSK1), deficiency or leptin receptor (LEPR) deficiency
How you reintroduce a liquid to it determines whether it remains a viable research compound or becomes a vial of expensive, useless amino acids
& Albrecht, J
Foundational research is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Healths PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies on NNMT inhibitor cellular biology and 5-Amino-1MQ specifically
